glp-1 injections palo alto Personalized Injection Are GLP-1 compounds safe? Not

Although GLP-1RAs can reduce body weight by 15%25% in controlled settings, real-world adherence is limited, and nearly 70% of patients experience weight regain after discontinuation, raising the risk of long-term pharmacological dependence (Jensen et al., 2024)

Thats why many obesity specialists view these drugs as short-term tools , not permanent solutions

"There's some data to suggest that a dose tapering strategy, so where you minimize or lower the doses over time might prevent weight regain."

A study reported that berberine facilitates GLP-1 production by activating the -catenin/TCF4 signalling pathway and via miR-106b downregulation 3

Medicare covers some of the drugs for diabetes and other conditions

Still, this new work with cryo-EM technology may serve us as a reminder, albeit indirect, that not paying full attention to adverse effects of undetected and unmanaged hyperinsulinism, the first dimension of insulin dysregulation, leaves much to be desired